Laura Arellano-García

Dr. Laura Arellano-García


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
LALaura Isabel Arellano-García
Laura Isabel Arellano-García
JTJENIFER TREPIANA
JENIFER TREPIANA
JMJ. Alfredo Martínez
J. Alfredo Martínez
MPMaria P. Portillo
Maria P. Portillo
Iñaki Milton-LaskibarIñaki Milton-Laskibar
Iñaki Milton-Laskibar
Oxidative stress and inflammation are well-known triggers of NAFLD onset and progression. The aim of this study is to compare the potential benefits of a viable probiotic (Lactobacillus rhamnosus GG) and its parabiotic (heat-inactivated) on oxidative stress, inflammation, DNA damage and cell death pathways in the liver of rats featuring diet-induced NAFLD. The consumption of the steatotic diet led to increased final body and liver weights, higher hepatic triacylglycerol content, altered serum transaminase levels and enhanced oxidative and inflammatory status. Administration of the probiotic and the parabiotic partially prevented the body weight increase induced by the steatotic diet, whereas the probiotic caused more effective decreasing hepatic triglyceride content. Sharp but nonstatistically significant decreases in serum transaminase levels were also observed for both treatments. The reduction in antioxidant enzyme activities found in the nontreated animals fed the steatotic diet was partially prevented by both treatments (GPx activity). Similarly, the reductions in nonenzymatic antioxidant protection (GSH content) and total antioxidant capacity (ORAC) found in the nontreated rats were restored by the administration of both treatments. These results show that both viable and heat-inactivated Lactobacillus rhamnosus GG administration partially prevent steatotic diet-induced liver oxidative stress and inflammation induced in rats.

Verified
Journal Article
Open access
PDF file
LALaura Isabel Arellano-García
Laura Isabel Arellano-García
MPMaria P. Portillo
Maria P. Portillo
JMJ. Alfredo Martinez
J. Alfredo Martinez
Iñaki Milton-LaskibarIñaki Milton-Laskibar
Iñaki Milton-Laskibar
The present review aims at analyzing the current evidence regarding probiotic administration for non-alcoholic fatty liver disease (NAFLD) management. Additionally, the involved mechanisms of action modulated by probiotic administration, as well as the eventual limitations of this therapeutic approach and potential alternatives, are discussed. Preclinical studies have demonstrated that the administration of single-strain probiotics and probiotic mixtures effectively prevents diet-induced NAFLD. In both cases, the magnitude of the described effects, as well as the involved mechanisms of action, are comparable, including reduced liver lipid accumulation (due to lipogenesis downregulation and fatty acid oxidation upregulation), recovery of gut microbiota composition and enhanced intestinal integrity. Similar results have also been reported in clinical trials, where the administration of probiotics proved to be effective in the treatment of NAFLD in patients featuring this liver condition. In this case, information regarding the mechanisms of action underlying probiotics-mediated hepatoprotective effects is scarcer (mainly due to the difficulty of liver sample collection). Since probiotics administration represents an increased risk of infection in vulnerable subjects, much attention has been paid to parabiotics and postbiotics, which seem to be effective in the management of several metabolic diseases, and thus represent a suitable alternative to probiotic usage.

2 September 2023 in Food & Function
Verified
Journal Article
Open access
PDF file
LALaura Isabel Arellano-García
Laura Isabel Arellano-García
MMMaria Teresa Macarulla
Maria Teresa Macarulla
ACAmanda Cuevas-Sierra
Amanda Cuevas-Sierra
JMJosé Alfredo Martínez
José Alfredo Martínez
MPMaria P. Portillo
Maria P. Portillo
Iñaki Milton-LaskibarIñaki Milton-Laskibar
Iñaki Milton-Laskibar
Insulin resistance and type 2 diabetes are obesity-related health alterations, featuring an ever-increasing prevalence.

Verified
Journal Article
Open access
PDF file
SGSaioa Gómez-Zorita
Saioa Gómez-Zorita
Iñaki Milton-LaskibarIñaki Milton-Laskibar
Iñaki Milton-Laskibar
LALaura Isabel Arellano-García
Laura Isabel Arellano-García
MGmarcela González
marcela González
MPMaria P. Portillo
Maria P. Portillo
The present review is aimed at analysing the current evidence concerning the potential modulation of obesity and/or diet in adipose tissue ACE2. Additionally, the potential implications of these effects on COVID-19 are also addressed. The results published show that diet and obesity are two factors that effectively influence the expression of Ace2 gene in adipose tissue. However, the shifts in this gene do not always occur in the same direction, nor with the same intensity. Additionally, there is no consensus regarding the implications of increased adipose tissue ACE2 expression in health. Thus, while in some studies a protective role is attributed to ACE2 overexpression, other studies suggest otherwise. Similarly, there is much debate regarding the role played by ACE2 in COVID-19 in terms of degree of infection and disease outcomes. The greater risk of infection that may hypothetically derive from enhanced ACE2 expression is not clear since the functionality of the enzyme seems to be as important as the abundance. Thus, the greater abundance of ACE2 in adipose tissue of obese subjects may be counterbalanced by its lower activation. In addition, a protective role of ACE2 overexpression has also been suggested, associated with the increase in anti-inflammatory factors that it may produce.

8 November 2022 in Journal of Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
Iñaki Milton-LaskibarIñaki Milton-Laskibar
Iñaki Milton-Laskibar
JTJENIFER TREPIANA
JENIFER TREPIANA
MMMaría Teresa Macarulla
María Teresa Macarulla
SGSaioa Gómez-Zorita
Saioa Gómez-Zorita
LALaura Isabel Arellano-García
Laura Isabel Arellano-García
MPMaria P. Portillo
Maria P. Portillo
The Mediterranean diet is a dietary pattern typical of the populations living in the Mediterranean basin during the 50s-60s of the last century. This diet has demonstrated beneficial effects in the prevention of several pathologies such as cardiovascular diseases, metabolic syndrome, or several cancer types, at least in part, due to its antioxidant compounds. Since the COVID-19 pandemic started, different authors have been studying the effects of certain dietary habits on the presence of COVID-19 and its severity, and the Mediterranean diet is one of them. This review gathers data from studies supporting the potential usefulness of the main phenolic compounds present in the Mediterranean diet, based on their antioxidant and anti-inflammatory effects, as preventive/therapeutic agents against COVID-19. The current evidence supports the potential benefits that hydroxytyrosol, resveratrol, flavonols such as quercetin, flavanols like catechins, and flavanones on the order of naringenin could have on COVID-19. This is due to the increase in the synthesis and translocations of Nrf-2, which increases the activity of antioxidant enzymes and thus reduces ROS production, the scavenging of free radicals, and the suppression of the activity of MMP-9, which is involved in the cytokine storm, and the inhibition of NF-κB.

26 February 2026 in Current Nutrition Reports
Verified
Journal Article
Open access
PDF file
LALaura Isabel Arellano-García
Laura Isabel Arellano-García
MPMaria P. Portillo
Maria P. Portillo
AHAnna Hadjihambi
Anna Hadjihambi
JMJ. Alfredo Martinez
J. Alfredo Martinez
Iñaki Milton-LaskibarIñaki Milton-Laskibar
Iñaki Milton-Laskibar
Purpose of review: This narrative review analyses the implication of obesity-associated gut microbiota dysbiosis, as well as the associated impairments in gut-brain axis communication, in the onset and development of this chronic metabolic disease. Recent findings: Gut microbiota dysbiosis, which is a common feature in individuals with obesity, is considered among the factors leading to its development. In fact, dietary habits not only modulate the composition of gut microbiota, but also the release of microbe-derived metabolites such as SCFAs, which in turn participate in the gut-brain axis communication. Interestingly, the approaches often used for obesity management, including lifestyle modification-based interventions, pharmacotherapy or the usage of bioactives (such as phenolic compounds or probiotics) have also been shown to restore the impairments in gut-brain axis communication associated to this disease. In this regard, the recovery of gut microbiota eubiosis and improvement of the intestinal barrier function, as well as the modulation of microbial metabolite production, have been described as potential underlying mechanisms of action. Summary: The review highlights the importance of the gut-brain axis in obesity, both in the development as well as the management of this chronic metabolic disease. However, further research is warranted in order to corroborate the current findings and to better elucidate the mechanisms underlying this complex signalling network. Doing so, valuable information that will pave the way for the development of more specific and effective obesity treatments may be obtained.